- Effect of Mizagliflozin on Postprandial Plasma Glucose in Patients With Functional Constipation
-
Fukudo S, Kaku K
- KMID: 2449104
- J Neurogastroenterol Motil.
- 2019 Apr;25(2):332-333.
- doi: 10.5056/jnm19010
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Biopsychosocial Model of Irritable Bowel Syndrome
-
Tanaka Y, Kanazawa M, Fukudo S, Drossman D
- KMID: 2326206
- J Neurogastroenterol Motil.
- 2011 Apr;17(2):131-139.
Irritable bowel syndrome (IBS) is a common chronic disorder seen in gastroenterology and primary care practice. It is characterized by recurrent abdominal pain or discomfort associated with disturbed bowel function.... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Irritable Bowel Syndrome in Japan, China, and South Korea: An International Cross-sectional Study
-
Takeoka A, Kimura T, Hara S, Hamaguchi T, Fukudo S, Tayama J
- KMID: 2541575
- J Neurogastroenterol Motil.
- 2023 Apr;29(2):229-237.
- doi: 10.5056/jnm22037
Background/Aims Symptoms of irritable bowel syndrome (IBS), a common gut-brain interaction disorder, deteriorate patients’ quality of life and increase medical needs; therefore, IBS represents a significant global burden. The estimated global... -
- CITED
-
- Close
- SHARE
-
- Close
- Dai-Kenchu-To, a Herbal Medicine, Attenuates Colorectal Distention-induced Visceromotor Responses in Rats
-
Nakaya K, Nagura Y, Hasegawa R, Ito H, Fukudo S
- KMID: 2433462
- J Neurogastroenterol Motil.
- 2016 Oct;22(4):686-693.
- doi: 10.5056/jnm15190
BACKGROUND/AIMS: Dai-kenchu-to (DKT), a traditional Japanese herbal medicine, is known to increase gastrointestinal motility and improve ileal function. We tested our hypotheses that (1) pretreatment with DKT would block the... -
- CITED
-
- Close
- SHARE
-
- Close
- Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study
-
Tanaka Y, Kanazawa M, Palsson OS, Van Tilburg MA, Gangarosa , Fukudo S, Drossman D, Whitehead
- KMID: 2417276
- J Neurogastroenterol Motil.
- 2018 Jan;24(1):87-95.
- doi: 10.5056/jnm16216
BACKGROUND/AIMS: The prevalence and severity of irritable bowel syndrome (IBS) declines with age, but the cause of this is unknown. This study tested 2 hypotheses: (1) autonomic nervous system responses... -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding Neurogastroenterology From Neuroimaging Perspective: A Comprehensive Review of Functional and Structural Brain Imaging in Functional Gastrointestinal Disorders
-
Kano M, Dupont P, Aziz Q, Fukudo S
- KMID: 2422842
- J Neurogastroenterol Motil.
- 2018 Oct;24(4):512-527.
- doi: 10.5056/jnm18072
This review provides a comprehensive overview of brain imaging studies of the brain-gut interaction in functional gastrointestinal disorders (FGIDs). Functional neuroimaging studies during gut stimulation have shown enhanced brain responses... -
- CITED
-
- Close
- SHARE
-
- Close
- Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
-
Kanazawa M, Nakajima S, Oshima T, Whitehead , Sperber AD, Palsson OS, Drossman D, Miwa H, Fukudo S
- KMID: 2381302
- J Neurogastroenterol Motil.
- 2015 Oct;21(4):537-544.
- doi: 10.5056/jnm15016
BACKGROUND/AIMS: Reliable diagnostic instruments for measuring the presence of functional gastrointestinal disorders based on the Rome III criteria have been lacking in Japan. The aims of the present study were... -
- CITED
-
- Close
- SHARE
-
- Close
- Second Asian Consensus on Irritable Bowel Syndrome
-
Gwee KA, Gonlachanvit S, Ghoshal UC, Chua AS, Miwa H, Wu J, Bak YT, Lee OY, Lu CL, Park H, Chen M, Syam AF, Abraham P, Sollano J, Chang CS, Suzuki H, Fang X, Fukudo S, Choi MG, Hou X, Hongo M
- KMID: 2454634
- J Neurogastroenterol Motil.
- 2019 Jul;25(3):343-362.
- doi: 10.5056/jnm19041
BACKGROUND/AIMS: There has been major progress in our understanding of the irritable bowel syndrome (IBS), and novel treatment classes have emerged. The Rome IV guidelines were published in 2016 and... -
- CITED
-
- Close
- SHARE
-
- Close
